New Zealand Veterinary Journal ISSN: (Print) (Online) Journal homepage: www.tandfonline.com/journals/tnzv20 Prevalence of the ABCB1-1Δ gene mutation in a sample of New Zealand Huntaway dogs K Gedye, E Poole-Crowe, M Shepherd, A Wilding, K Parton, N Lopez-Villalobos & N Cave To cite this article: K Gedye, E Poole-Crowe, M Shepherd, A Wilding, K Parton, N Lopez- Villalobos & N Cave (2023) Prevalence of the ABCB1-1Δ gene mutation in a sample of New Zealand Huntaway dogs, New Zealand Veterinary Journal, 71:3, 133-136, DOI: 10.1080/00480169.2023.2181238 To link to this article: https://doi.org/10.1080/00480169.2023.2181238 © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group Published online: 13 Mar 2023. Submit your article to this journal Article views: 830 View related articles View Crossmark data Citing articles: 1 View citing articles Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=tnzv20 https://www.tandfonline.com/journals/tnzv20?src=pdf https://www.tandfonline.com/action/showCitFormats?doi=10.1080/00480169.2023.2181238 https://doi.org/10.1080/00480169.2023.2181238 https://www.tandfonline.com/action/authorSubmission?journalCode=tnzv20&show=instructions&src=pdf https://www.tandfonline.com/action/authorSubmission?journalCode=tnzv20&show=instructions&src=pdf https://www.tandfonline.com/doi/mlt/10.1080/00480169.2023.2181238?src=pdf https://www.tandfonline.com/doi/mlt/10.1080/00480169.2023.2181238?src=pdf http://crossmark.crossref.org/dialog/?doi=10.1080/00480169.2023.2181238&domain=pdf&date_stamp=13%20Mar%202023 http://crossmark.crossref.org/dialog/?doi=10.1080/00480169.2023.2181238&domain=pdf&date_stamp=13%20Mar%202023 https://www.tandfonline.com/doi/citedby/10.1080/00480169.2023.2181238?src=pdf https://www.tandfonline.com/doi/citedby/10.1080/00480169.2023.2181238?src=pdf https://www.tandfonline.com/action/journalInformation?journalCode=tnzv20 BRIEF REPORT Prevalence of the ABCB1-1Δ gene mutation in a sample of New Zealand Huntaway dogs K Gedye a, E Poole-Croweb, M Shepherdc, A Wildingd, K Parton a, N Lopez-Villalobos e and N Cavea aTāwharau Ora – School of Veterinary Science, Massey University, Palmerston North, New Zealand; bVE Veterinary Services Ltd, Te Awamutu, New Zealand; cWarkworth Vets, Warkworth, New Zealand; dPet Emergency, Stafford, Australia; eSchool of Agriculture and the Environment, Massey University, Palmerston North, New Zealand ABSTRACT Aims: To determine the prevalence of the ATP Binding Cassette Subfamily B Member 1-1Δ mutation (ABCB1-1Δ; previously Multidrug Resistance 1 (MDR1) mutation) in a cohort of New Zealand Huntaway dogs. Materials and methods: Samples were opportunistically collected from Huntaway dogs (n = 189) from throughout New Zealand. Buccal swabs were collected from 42 Huntaways from the Wairarapa region and 147 blood samples from Huntaways from the Gisborne, Waikato, Manawatū/Whanganui, Hawkes Bay, Canterbury and Otago regions. DNA was extracted from all samples and tested for the presence of the ABCB1-1Δ allele. Results: Of 189 Huntaway dogs that were tested, two were found to be heterozygous carriers of the ABCB1-1Δ allele and the remaining 187/189 dogs were homozygous for the wild type allele. No dogs homozygous for the mutation were identified. Conclusions and clinical relevance: The results of this study show that the ABCB1-1Δ allele is present in Huntaway dogs. The low prevalence in this convenience sample suggests that the prevalence of this allele in the Huntaway population is likely to be low. We recommend that veterinary clinicians discuss the potential for this mutation in Huntaways with dog owners including the clinical implications for dogs that are homozygous for the mutated allele and the potential for testing for the mutation, as they would do for other known mutations. Abbreviations: ABCB1: ATP Binding Cassette Subfamily B Member 1; CNS: Central nervous system; MDR1 test: Multidrug resistance 1 gene test ARTICLE HISTORY Received 5 July 2022 Accepted 6 February 2023 Published online 14 February 2023 KEYWORDS Huntaway; dog; ABCB1-1Δ; multiple drug resistance; prevalence Introduction The New Zealand Huntaway is characterised as a working farm dog, and as such is bred for traits suitable to their work of moving stock (sheep and cattle) on New Zealand farms. The Huntaway is typically used to drive stock forwards and has been bred and selected for its physical endurance and a deep, loud bark, rather than to conform to an arbitrary set of physical charac- teristics (Oliver et al. 2009). The Huntaway has become an iconic part of New Zealand society, but to date little is known of their history and genetics. A major assump- tion regarding the pedigree of the Huntaway is that the breed is descended from herding dog breeds, including Border Collie and Rough Coated Collie breeds (Anonymous 2022). Additional breeds thought to be progenitors of the Huntaway include Labrador, Rottweiler, Harrier Hound, Gordon Setter and Smithfield Collie (Dogs New Zealand 2022). The potential for Huntaways to be descended from Collie breeds is notable because Collies have been shown to carry a mutation in the ABCB1 (ATP Binding Cassette Subfamily B Member 1) gene, which encodes P-glycoprotein, an ATP-dependent drug transporter that moves several substances across the blood–brain barrier and protects the brain from xeno- biotic toxicity (Mealey et al. 2001; Glavinas et al. 2004). ABCB1 was previously known as the multi drug resist- ance (MDR1) gene. The mutation, denoted ABCB1-1Δ, is a nonsense mutation, consisting of a 4-bp deletion in the fourth exon in the ABCB1 gene (Neff et al. 2004). The ABCB1-1Δ allele is present in 4.8–61.2% of some Collie populations in Germany (Geyer et al. 2005a; Gramer et al. 2011), Brazil (Monobe et al. 2015), Israel (Dekel et al. 2017) and the USA (Neff et al. 2004) that have been tested, and can also be found in breeds descended from Collies, such as the Australian Shepherd (Neff et al. 2004). Neff et al. (2004) hypothesised that as the ABCB1-1Δ allele was conserved among different breeds, it was identical by descent and originated in an ancestral dog that occurred in the UK around 1873, indicating that all modern dogs containing the mutation are potentially related. © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by- nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. CONTACT K Gedye k.gedye@massey.ac.nz NEW ZEALAND VETERINARY JOURNAL 2023, VOL. 71, NO. 3, 133–136 https://doi.org/10.1080/00480169.2023.2181238 http://crossmark.crossref.org/dialog/?doi=10.1080/00480169.2023.2181238&domain=pdf&date_stamp=2023-03-16 http://orcid.org/0000-0003-2808-6195 http://orcid.org/0000-0002-4234-9919 http://orcid.org/0000-0001-6611-907X http://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ mailto:k.gedye@massey.ac.nz http://www.tandfonline.com The P-glycoprotein encoded by ABCB1 is a large transmembrane efflux protein located in the brain, and in the intestine, bile canaliculi and renal tubules (Mealey 2008). Many drugs that are substrates for P- glycoprotein are in common use in veterinary medi- cine. Macrocyclic lactones are one such drug family to which Huntaways may be exposed either as a treat- ment or inadvertently (Mealey 2008; Parton et al. 2012). The ABCB1-1Δ mutation was identified through signs of central nervous system (CNS) dysfunction first observed in dogs that developed neurotoxicity fol- lowing treatment with ivermectin, a macrocyclic lactone used to treat a variety of endo- and ecto-para- sites (Seward 1983). Ivermectin and other macrocyclic lactone drugs bind to chloride channels in the nervous system of nematodes and arthropods, causing an influx of chloride ions; this suppresses synaptic transmission and leads to paralysis and death of the invertebrate. Mammals have homologous target molecules, however these are restricted to the CNS and protected by the blood–brain barrier. P-glyco- protein is a component of the blood–brain barrier and transports a broad array of substrates, thus protecting the brain from neurotoxic substances. Individuals homozygous for the ABCB1-1Δ mutation do not express functionally intact P-glycoprotein. Studies in knockout mice lacking the ABCB1 gene found increased ivermectin levels in brain tissue and a decrease in drug elimination (Schinkel et al. 1994). Subsequently it has been shown that several drugs that are normally exported from the CNS via the P-gly- coprotein can also be toxic at normally therapeutic doses in dogs homozygous for the ABCB1-1Δmutation (Henik et al. 2006; Krugman et al. 2012; Campbell et al. 2017). Dogs with this mutation show increased sensi- tivity to many P-glycoprotein-transported drugs in addition to ivermectin, including moxidectin, milbe- mycin oxime, acepromazine, butorphanol, digoxin, vincristine and loperamide (Mealey 2008). Further- more, studies have shown an intermediate phenotype for heterozygous dogs (Mealey and Meurs 2008; Coelho et al. 2009) for some P-glycoprotein substrates, however this has not been established for macrocyclic lactones. Macrocyclic lactones are widely used on farms in New Zealand and toxicity in dogs has been previously recorded (Parton et al. 2012). Thus, any increased susceptibility to toxicosis in working farm dogs is especially salient. Given that Collies and other herding dogs may be progenitors of the Huntaway, it is important to deter- mine if the ABCB1-1Δ allele is present in the population of Huntaway dogs. There is an obvious interest in testing various herding dogs descended from Collie breeds; some investigation of the ABCB1-1Δ allele in other potential Huntaway progenitor breeds (Rottweiler and Labrador) has occurred without the allele having so far been found (Mealey and Meurs 2008; Bissonnette et al. 2009). To date, no examination of the Huntaway breed for the presence of the ABCB1-1Δ mutation has occurred. The aim of this study was therefore to deter- mine the prevalence of the ABCB1-1Δ mutation in a sample of New Zealand Huntaway dogs. Materials and methods Two cohorts of dogs were examined in this study. The first was an opportunistic collection of 42 buccal swabs obtained from Huntaway dogs from farms in the Wairarapa region of New Zealand between January and March 2019. The dogs in this study were sampled from five farms with 2–15 dogs sampled per farm. Swabs were stored for approximately 1 month at −20°C prior to extraction. The second cohort was also an opportunistic collection, comprising 147 blood samples originally collected for a different study between January 2019 and April 2021; these were all working Huntaway dogs from farms in the following regions: Gisborne, Waikato, Manawatū/Whanganui, Hawke’s Bay, Canterbury and Otago. Blood was col- lected into vacutainers containing EDTA and stored for 1–3 months at −80°C prior to DNA extraction. The dogs in this study were sampled from 112 farms with 1–10 dogs sampled per farm. Both collections were approved by the Massey University Animal Ethics Com- mittee (approval numbers 19/74 and 18/27 respectively). DNA from the buccal swabs was extracted using a Chelex protocol (Martín-Platero et al. 2010). DNA from the blood samples was extracted with the NucleoSpin Blood kit (Macherey-Nagel, Düren, Germany) according to the manufacturer’s instructions. DNA from both extraction protocols was quantified using a NanoDrop 2000 (ThermoFisher, Waltham, MA, USA). DNA from all samples was submitted to InfoGeneNZ at Massey University (Palmerston North, NZ) for their canine genetic health screening MDR1 test. The MDR1 test uses a protocol developed by Geyer et al. (2005b), which amplifies a 138-bp fragment from the wild-type ABCB1 gene and a 134-bp fragment from the ABCB1- 1Δ allele that has the 4-bp deletion. Visualisation of the amplified product occurs via fluorescence using an Applied Biosystems 3500xL Genetic Analyzer (Thermo- Fisher, Waltham, MA, USA). Results of this analysis for a normal (wild type) individual is a 138-bp amplicon; a carrier will have both a 138-bp and a 134-bp amplicon, while individuals homozygous for the mutant allele will have a single amplicon of 134 bp. The MDR1 test only identifies the presence or absence of the ABCB1-1Δ allele and no other potential variants of the ABCB1 gene. Results Amplicons of the expected sizes were successfully amplified with the MDR1 test from all DNA samples (n = 189), allowing identification of individuals carrying 134 K GEDYE ET AL. the ABCB1-1Δ allele. In total 2/189 dogs were found to be carriers of the ABCB1-1Δ mutation, one from the Wairarapa region (cohort 1) and the other from Hawke’s Bay (cohort 2). No dogs homozygous for the mutation were identified. Discussion Although the exact ancestry of the New Zealand Hunt- away is unknown, it is thought to include Collie dogs that had originated in the UK. Given the high preva- lence of the ABCB1-1Δ mutation in Collies worldwide, (Neff et al. 2004; Monobe et al. 2015; Dekel et al. 2017), it was hypothesised that the prevalence of this mutation in Huntaways might also be high. While we did identify the ABCB1-1Δ mutation in the sample of dogs included in this study, it was at a very low rate. As this study did not test a systematic random sample of Huntaways from the population in New Zealand, we cannot be certain the mutation is present at similarly low prevalence in the population as a whole. Presuming it is, it is unknown if the low presence of this mutation is due to a fortuitous founder effect during the initial breeding of Huntaway progenitors in New Zealand, or due to the inadvertent removal of dogs containing the mutation due to unre- ported attrition. However, the low frequency of the mutation found in this study is of some comfort to Huntaway owners. Macrocyclic lactones have been used in dogs for treatment of a range of endo- and ectoparasites, including gastrointestinal nematodes (e.g. Ancylos- toma spp., Toxocara spp.), mites (e.g. Demodex canis, Otodectes cynotis, Sarcoptes scabei), fleas, and some species of ticks (Nolan and Lok 2012). In addition, inad- vertent exposure can occur; for example, farm dogs may come into contact with livestock treated with pour-on formulae (Parton et al. 2012). Therefore, it was important to establish the susceptibility of the uniquely New Zealand Huntaway breed to toxicosis. Although toxicosis was not found to be a very common reason for presentation to veterinary prac- tices in a survey of working farm dog diseases (Cave et al. 2009), it was considered possible that toxicity resulting in the death of dogs on-farm might not be reported to veterinarians. Based on this research, while it is possible for any individual Huntaway to be homozygous for the ABCB1-1Δ mutation, this should be considered very unlikely. While this study did include a moderate number of dogs, we used an opportunistic rather than a systema- tic random sampling strategy, and dogs were sourced from predominantly the North Island. Therefore, as mentioned above, the allele prevalence found in this sample of dogs cannot be extrapolated to the whole population of Huntaway dogs in New Zealand. The Huntaway has far more diverse phenotypic characteristics than other breeds, and there may be geographical regions where dogs are genetically different to those included in this study. However, it is argued that trading of dogs, transport of dogs for planned matings, and movement of farmers and their animals around the country continue to hom- ogenise the genetic pool beyond simple geographic regions, and increase the confidence of this inference. Our data suggest that while the ABCB1-1Δmutation is present in the New Zealand Huntaway population, its prevalence in the population as a whole is likely to be very low; dogs homozygous for this allele, and therefore susceptible to macrocyclic lactone toxicosis, are likely to be even rarer. A thorough investigation into the genetic diversity of Huntaway dogs through- out New Zealand would be beneficial for better under- standing the population. The New Zealand Huntaway is a recently defined dog breed, with much of its pedi- gree either unknown or historical hearsay. Additional investigations into the genetics of this breed would be beneficial for understanding disease in the popu- lation and to provide historical provenance. Testing of dogs for the mutation is sensible prior to the admin- istration of drugs with a low therapeutic window that are transported by P-glycoprotein, (e.g. macrocyclic lactones), particularly those which have been reported to affect heterozygotes, such as vincristine (Mealey and Meurs 2008). However, unlike the Collie breeds, the results of this study do not suggest that the Huntaway is at particular risk relevant to other breeds. Testing for the ABCB1-1Δ mutation is now easily and inexpen- sively performed in New Zealand through InfoGeneNZ. Acknowledgements Thanks to Alanda Rafferty from Veterinary Enterprises Group (VetEnt) for the supply of numerous blood samples for this research. Funding was provided by Tāwharau Ora – School of Veterinary Science, Massey University, via the Lewis Fitch Research Fund. ORCID K Gedye http://orcid.org/0000-0003-2808-6195 K Parton http://orcid.org/0000-0002-4234-9919 N Lopez-Villalobos http://orcid.org/0000-0001-6611-907X References *Anonymous. Huntaway. https://en.wikipedia.org/wiki/ Huntaway (accessed 21 April 2022). Wikipedia, San Francisco, CA, USA, 2022 Bissonnette S, Paradis M, Daneau I, Silversides DW. The ABCB1-1Δ mutation is not responsible for subchronic neu- rotoxicity seen in dogs of non-Collie breeds following macrocyclic lactone treatment for generalized demodico- sis. Veterinary Dermatology 20, 60–6, 2009. https://doi.org/ 10.1111/j.1365-3164.2008.00731.x NEW ZEALAND VETERINARY JOURNAL 135 http://orcid.org/0000-0003-2808-6195 http://orcid.org/0000-0002-4234-9919 http://orcid.org/0000-0001-6611-907X https://en.wikipedia.org/wiki/Huntaway https://en.wikipedia.org/wiki/Huntaway https://doi.org/10.1111/j.1365-3164.2008.00731.x https://doi.org/10.1111/j.1365-3164.2008.00731.x Campbell O, de Lorimier LP, Mealey KL. Adverse reaction to apomorphine in a Collie homozygous for the ABCB1- 1Δ (MDR1) mutation. Journal of Small Animal Practice 52, 119, 2017. https://doi.org/10.1111/jsap.12618 Cave NJ, Bridges JP, Cogger N, Farman RS. A survey of dis- eases of working farm dogs in New Zealand. New Zealand Veterinary Journal 57, 305–12, 2009. https://doi.org/10. 1080/00480169.2009.60926 Coelho JC, Tucker R, Mattoon J, Roberts G, Waiting DK, Mealey KL. Biliary excretion of technetium-99m-sestamibi in wild-type dogs and in dogs with intrinsic (ABCB1-1Δ mutation) and extrinsic (ketoconazole treated) P-glyco- protein deficiency. Journal of Veterinary Pharmacology and Therapeutics 32, 417–21, 2009. https://doi.org/10. 1111/j.1365-2885.2009.01068.x Dekel Y, Machluf Y, Stoler A, Aderet A, Baumel D, Kellerman E, Plotsky Y, Partouche ON, Elhalal G, Ben- Shlomo I, et al. Frequency of canine nt230 (del4) MDR1 mutation in prone pure breeds, their crosses andmongrels in Israel – insights from a worldwide comparative perspec- tive. BMC Veterinary Research 13, 1–8, 2017. https://doi. org/10.1186/s12917-017-1251-9 *Dogs New Zealand. Dogs New Zealand: NZ Huntaway: Information and NZ Breed Standards. https://www. dogsnz.org.nz/breeds/info/nz-huntaway/535 (accessed 5 September 2022). Dogs New Zealand, Porirua, NZ, 2022 Geyer J, Döring B, Godoy JR, Leidolf R, Moritz A, Petzinger E. Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany. Journal of Veterinary Pharmacology and Therapeutics 28, 545–51, 2005a. https:// doi.org/10.1111/j.1365-2885.2005.00692.x Geyer J, Döring B, Godoy JR, Moritz A, Petzinger E. Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a mox- idectin-sensitive Australian Shepherd. Journal of Veterinary Pharmacology and Therapeutics 28, 95–9, 2005b. https:// doi.org/10.1111/j.1365-2885.2004.00625.x Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and tox- icity. Current Drug Delivery 1, 27–42, 2004. https://doi.org/ 10.2174/1567201043480036 Gramer I, Leidolf R, Döring B, Klintzsch S, Krämer EM, Yalcin E, Petzinger E, Geyer J. Breed distribution of the nt230 (del4) MDR1 mutation in dogs. The Veterinary Journal 189, 67–71, 2011. https://doi.org/10.1016/j.tvjl. 2010.06.012 Henik RA, Kellum HB, Bentjen SA, Mealey KL. Digoxin and mexiletine sensitivity in a Collie with the MDR1 mutation. Journal of Veterinary Internal Medicine 20, 415–7, 2006. https://doi.org/10.1111/j.1939-1676.2006.tb02878.x Krugman L, Bryan JN,Mealey KL, ChenA. Vincristine-induced central neurotoxicity in a Collie homozygous for the ABCB1Δ mutation. Journal of Small Animal Practice 53, 185–7, 2012. https://doi.org/10.1111/j.1748-5827.2011.01155.x Martín-Platero AM, Peralta-Sánchez JM, Soler JJ, Martínez-Bueno M. Chelex-based DNA isolation pro- cedure for the identification of microbial communities of eggshell surfaces. Analytical Biochemistry 397, 253–5, 2010. https://doi.org/10.1016/j.ab.2009.10.041 Mealey KL. Canine ABCB1 and macrocyclic lactones: heart- worm prevention and pharmacogenetics. Veterinary Parasitology 158, 215–22, 2008. https://doi.org/10.1016/j. vetpar.2008.09.009 Mealey KL, Meurs KM. Breed distribution of the ABCB1-1Δ (multidrug sensitivity) polymorphism among dogs under- going ABCB1 genotyping. Journal of the American Veterinary Medical Association 233, 921–4, 2008. https:// doi.org/10.2460/javma.233.6.921 Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in Collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11, 727–33, 2001. https://doi.org/10.1097/00008571-200111000-00012 Monobe MM, Junior JPA, Lunsford KV, Silva RC, Bulla C. Frequency of the MDR1 mutant allele associated with mul- tidrug sensitivity in dogs from Brazil. Veterinary Medicine 6, 111–7, 2015. https://doi.org/10.2147/VMRR.S72373 Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Pedersen NC. Breed distribution and history of canine mdr1–1Δ, a pharmacogenetic mutation that marks the emergence of breeds from the Collie lineage. Proceedings of the National Academy of Sciences 101, 11725–30, 2004. https://doi.org/10.1073/ pnas.0402374101 Nolan TJ, Lok JB. Macrocyclic lactones in the treatment and control of parasitism in small companion animals. Current Pharmaceutical Biotechnology 13, 1078–94, 2012. https:// doi.org/10.2174/138920112800399167 *Oliver M, Sheild T, Jerram P. I am a Working Dog. Natural Training for Sheepdogs. 2nd Edtn. Longacre Press, Dunedin, NZ, 2009 Parton K, Wiffen EM, Haglund ND, Cave NJ. Macrocyclic lactone toxicity due to abamectin in farm dogs without the ABCB1 gene mutation. New Zealand Veterinary Journal 60, 194–7, 2012. https://doi.org/10.1080/ 00480169.2011.642770 Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491–502, 1994. https://doi.org/10.1016/0092-8674(94)90212-7 Seward RL. Reactions in dogs given ivermectin. Journal of the American Veterinary Medical Association 183, 493, 1983 *Non-peer-reviewed 136 K GEDYE ET AL. https://doi.org/10.1111/jsap.12618 https://doi.org/10.1080/00480169.2009.60926 https://doi.org/10.1080/00480169.2009.60926 https://doi.org/10.1111/j.1365-2885.2009.01068.x https://doi.org/10.1111/j.1365-2885.2009.01068.x https://doi.org/10.1186/s12917-017-1251-9 https://doi.org/10.1186/s12917-017-1251-9 https://www.dogsnz.org.nz/breeds/info/nz-huntaway/535 https://www.dogsnz.org.nz/breeds/info/nz-huntaway/535 https://doi.org/10.1111/j.1365-2885.2005.00692.x https://doi.org/10.1111/j.1365-2885.2005.00692.x https://doi.org/10.1111/j.1365-2885.2004.00625.x https://doi.org/10.1111/j.1365-2885.2004.00625.x https://doi.org/10.2174/1567201043480036 https://doi.org/10.2174/1567201043480036 https://doi.org/10.1016/j.tvjl.2010.06.012 https://doi.org/10.1016/j.tvjl.2010.06.012 https://doi.org/10.1111/j.1939-1676.2006.tb02878.x https://doi.org/10.1111/j.1748-5827.2011.01155.x https://doi.org/10.1016/j.ab.2009.10.041 https://doi.org/10.1016/j.vetpar.2008.09.009 https://doi.org/10.1016/j.vetpar.2008.09.009 https://doi.org/10.2460/javma.233.6.921 https://doi.org/10.2460/javma.233.6.921 https://doi.org/10.1097/00008571-200111000-00012 https://doi.org/10.2147/VMRR.S72373 https://doi.org/10.1073/pnas.0402374101 https://doi.org/10.1073/pnas.0402374101 https://doi.org/10.2174/138920112800399167 https://doi.org/10.2174/138920112800399167 https://doi.org/10.1080/00480169.2011.642770 https://doi.org/10.1080/00480169.2011.642770 https://doi.org/10.1016/0092-8674(94)90212-7 Abstract Introduction Materials and methods Results Discussion Acknowledgements ORCID References << /ASCII85EncodePages false /AllowTransparency false /AutoPositionEPSFiles false /AutoRotatePages /PageByPage /Binding /Left /CalGrayProfile () /CalRGBProfile (Adobe RGB \0501998\051) /CalCMYKProfile (U.S. Web Coated \050SWOP\051 v2) /sRGBProfile (sRGB IEC61966-2.1) /CannotEmbedFontPolicy /Error /CompatibilityLevel 1.3 /CompressObjects /Off /CompressPages true /ConvertImagesToIndexed true /PassThroughJPEGImages false /CreateJobTicket false /DefaultRenderingIntent /Default /DetectBlends true /DetectCurves 0.1000 /ColorConversionStrategy /sRGB /DoThumbnails true /EmbedAllFonts true /EmbedOpenType false /ParseICCProfilesInComments true /EmbedJobOptions true /DSCReportingLevel 0 /EmitDSCWarnings false /EndPage -1 /ImageMemory 524288 /LockDistillerParams true /MaxSubsetPct 100 /Optimize true /OPM 1 /ParseDSCComments false /ParseDSCCommentsForDocInfo true /PreserveCopyPage true /PreserveDICMYKValues true /PreserveEPSInfo false /PreserveFlatness true /PreserveHalftoneInfo false /PreserveOPIComments false /PreserveOverprintSettings false /StartPage 1 /SubsetFonts true /TransferFunctionInfo /Remove /UCRandBGInfo /Remove /UsePrologue false /ColorSettingsFile () /AlwaysEmbed [ true ] /NeverEmbed [ true ] /AntiAliasColorImages false /CropColorImages true /ColorImageMinResolution 150 /ColorImageMinResolutionPolicy /OK /DownsampleColorImages true /ColorImageDownsampleType /Bicubic /ColorImageResolution 300 /ColorImageDepth -1 /ColorImageMinDownsampleDepth 1 /ColorImageDownsampleThreshold 1.50000 /EncodeColorImages true /ColorImageFilter /DCTEncode /AutoFilterColorImages false /ColorImageAutoFilterStrategy /JPEG /ColorACSImageDict << /QFactor 0.90 /HSamples [2 1 1 2] /VSamples [2 1 1 2] >> /ColorImageDict << /QFactor 0.40 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000ColorACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /JPEG2000ColorImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 150 /GrayImageMinResolutionPolicy /OK /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 300 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages false /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict << /QFactor 0.90 /HSamples [2 1 1 2] /VSamples [2 1 1 2] >> /GrayImageDict << /QFactor 0.40 /HSamples [1 1 1 1] /VSamples [1 1 1 1] >> /JPEG2000GrayACSImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /JPEG2000GrayImageDict << /TileWidth 256 /TileHeight 256 /Quality 15 >> /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 1200 /MonoImageMinResolutionPolicy /OK /DownsampleMonoImages true /MonoImageDownsampleType /Average /MonoImageResolution 300 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict << /K -1 >> /AllowPSXObjects true /CheckCompliance [ /None ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile (None) /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False /Description << /ENU () >> >> setdistillerparams << /HWResolution [600 600] /PageSize [595.245 841.846] >> setpagedevice